Infusion Treatments of Chronic Peripheral Neuropathic Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

102 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-17

Study Completion Date

2023-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to evaluate and compare the efficacy of ketamine and lidocaine infusion in patients with chronic peripheral neuropathic pain.

Patients who received intravenous ketamine infusion and the other patient group who received intravenous lidocaine infusion were evaluated in the study. Pain scores and quality of life were assessed with scales before treatment at two weeks, two months, and six months after treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ketamine and Neuropathic Pain

NCT02467517

Neuropathic Pain

UNKNOWN PHASE2

Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain

NCT02597257

Postherpetic Neuralgia Diabetic Polyneuropathy Peripheral Neuropathy

UNKNOWN PHASE2

Oral Ketamine Administration in Patients With Peripheral Neuropathic Pain

NCT00961194

Neuropathic Pain

COMPLETED PHASE2

Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin Pathway

NCT03513822

Neuralgia Chronic Pain Inflammation

UNKNOWN PHASE3

IV Lidocaine Infusion for Neuropathic Pain

NCT05731739

Neuropathic Pain Complex Regional Pain Syndrome Chronic Pain

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study, it was aimed to evaluate and compare the efficacy of intravenous infusion of ketamine and lidocaine, which have been known and used in pain management and which have recently increased interest in the treatment of peripheric neuropathic pain.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuropathic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ketamine

Ketamine infusion was administered at 1 mg/kg (in 1 hour)

Intervention Type DRUG

Lidocain

Lidocaine infusion was administered at 3 mg/kg (in 1 hour)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Group K Group L

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-65 years of age
* Patients with peripheral neuropathic pain (radicular neuropathy, diabetic neuropathy, complex regional pain syndrome type 2, traumatic peripheral nerve injury, trigeminal neuralgia, postherpetic neuralgia)
* Patients who was evaluated by DN4 scores with of ≥4 points

Exclusion Criteria

* Patients with central nervous system disease .
* Patients with cancer related neuropatic pain.
* Patients with central neuropathic pain patterns.
* Patients with renal, hepatic, cardiovascular, and psychiatric diseases.
* Patients whose treatment could not be completed due to side effects or other reasons.
* Patients who had lost their follow-up .

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No